gms | German Medical Science

83. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

16.05. - 20.05.2012, Mainz

Artikel

Artikel empfehlen

Hyperbaric oxygenation for treatment of hearing loss and tinnitus

Meeting Abstract

Suche in Medline nach

  • corresponding author Katya Assenova - ENT Clinic, Military Medical Academy, Sofia, Bulgaria
  • Ventsislav Tsvetkov - Military Medical Academy, Sofia, Bulgaria
  • Stefan Stoyanov - Ministry of Interior Medical institute, Sofia, Bulgaria

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 83. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Mainz, 16.-20.05.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12hnod355

doi: 10.3205/12hnod355, urn:nbn:de:0183-12hnod3553

Veröffentlicht: 4. April 2012

© 2012 Assenova et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.

Gliederung

Text

Hyperbaric oxygen therapy (HBOT) is the medical use of oxygen at a level higher than atmospheric pressure. A related effect is the increased oxygen transport capacity of the blood. Patients with sudden hearing loss and tinnitus may have benefit from this treatment, because hypoxia is in fact main reason for inner ear damage.

Aim: To asses the role of HBOT in cases with hearing loss and tinnitus as adjuvant therapy.

Material and methods: 46 patients with SHL and tinnitus divided on two groups: Group I - treated only with medications and group II – with medications and HBOT. Average pure tone hearing levels (0.5, 1, 2 and 4KHz) were determined before and 2 weeks after treatment.

Results: HL improved by more than 20 dB in 32 % of the first group, and 54 % of the second group. Tinnitus intensity was reduced in 47 % in first group, and 72 % in second group. All patients had no adverse effects from the therapy.

Conclusion: Our results prove that HBOT as adjuvant therapy is a reliable method for treatment of sudden hearing loss and tinnitus.